Wednesday, November 20, 2013
Print Current Session:
|
|
Wednesday
SESSION 32:
NEW DEVELOPMENTS IN TREATING CRITICAL LOWER EXTREMITY ISCHEMIA (CLI) IN STENT RESTENOSIS (ISR), ATHERECTOMY AND MORE ON DESs
Moderators:Barry T. Katzen, MD / Frank J. Veith, MD
|
|
SESSION 32 SCHEDULE | |
10:00 AM - 10:05 AM | DEBATE: Importance Of Maintaining Revascularization Patency In CLI Patients: An Interventionalist’s View |
Presenter(s):Thomas Zeller, MD | |
10:06 AM - 10:11 AM | DEBATE: Importance Of Maintaining Revascularization Patency In CLI Patients: A Surgeon’s View |
Presenter(s):Frank E.G. Vermassen, MD, PhD | |
10:12 AM - 10:17 AM | Pedal Bypass With Deep Vein Arterialization Is Especially Applicable In Certain Specific Critical Ischemic Situations: Late Results |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
View Abstract | |
IN STENT RESTENOSIS (ISR) | |
10:18 AM - 10:23 AM | Insights Into The Pathogenesis Of ISR |
Presenter(s):Renu Virmani, MD | |
10:24 AM - 10:29 AM | DEBATE: DEBs Are The Best Treatment For ISR |
Presenter(s):Francesco Liistro, MD | |
10:30 AM - 10:35 AM | DEBATE: Covered Stents (Viabahn) Are The Best Treatment For ISR: Based On The RELINE Randomized Controlled Trial Comparing Them To Balloon PTA |
Presenter(s):Marc Bosiers, MD / Koen Deloose, MD | |
10:36 AM - 10:41 AM | DEBATE: Atherectomy Or Laser And DEBs Are The Best Treatment For ISR: Good Results Are Durable |
Presenter(s):Jos C. van den Berg, MD, PhD | |
10:42 AM - 10:47 AM | Optimal Treatment Of ISR: A US Perspective |
Presenter(s):Craig M. Walker, MD | |
ATHERECTOMY | |
10:48 AM - 10:53 AM | DEBATE: Atherectomy Will Not Become First Line Treatment Even Though The New Devices Are Better Than The Old |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
10:54 AM - 10:59 AM | DEBATE: Atherectomy Is Effective And Durable Treatment For Lower Extremity Occlusive Disease: Which Device Is Best |
Presenter(s):James F. McKinsey, MD | |
11:00 AM - 11:05 AM | Atherectomy Has Value In Association With DEBs For Fem-Pop Lesions: What Is The Value Of Cilostazol In Preventing Restenosis |
Presenter(s):Thomas Zeller, MD | |
11:06 AM - 11:11 AM | What Is The Future For Atherectomy After Past Failures And Conflicting Data |
Presenter(s):Sean P. Lyden, MD | |
11:12 AM - 11:17 AM | Atherectomy Is Of Little Value For Tibial Lesions |
Presenter(s):Jean M. Panneton, MD | |
MORE ON DRUG ELUTING STENTS (DES) ETC. | |
11:18 AM - 11:23 AM | DEBATE: New Findings From The ZILVER PTX Trial: Are The Benefits Of This DES Durable: Do The Good Results (3 Years And Beyond) Justify The Costs |
Presenter(s):Michael D. Dake, MD | |
11:24 AM - 11:29 AM | DEBATE: DEBs And Latest Generation Bare Metal Stents (BMS): Do They Obviate The Need For DESs |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
11:30 AM - 11:35 AM | What I Learned From European Vascular Specialists About Treating BTK Lesions |
Presenter(s):Peter A. Schneider, MD | |
11:36 AM - 11:41 AM | Overview Of The Newer And Old CTO Crossing Devices: What Are They And When Are They Useful |
Presenter(s):John H. Rundback, MD, FSIR, FAHA | |
11:42 AM - 11:47 AM | Decreasing Access Site Complications With Routine Ultrasound Guidance And Micropuncture Technique |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
11:48 AM - 11:59 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 32 | |
previous | next |